Lower adiponectin expression and circulating levels are associated with dysfunctional adiposity and precede the deterioration of insulin sensitivity in the prediabetic state [21], thus predicting the development of insulin resistance and T2DM [33,34]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.